Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 2, 1996, Pages 250-255

  Hopkins, Paul N ^a,d   Wu, Lily L ^a,b   Hunt, Steven C ^a   James, Brent C ^a   Michael Vincent, G ^c   Williams, Roger R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Cardiovasc Genetics Research Clinic   (United States)

Author keywords

case control studies; coronary artery disease; genetics; risk factors; serum bilirubin

Indexed keywords

ANTIOXIDANT; BILIRUBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; FAMILIAL DISEASE; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030063426     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.2.250     Document Type: Article

References (44)

1. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science. 1987;235:1043-1046.
2. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A. 1987;84:5918-5922.
3. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 1990;186:301-309.
4. Neuzil J, Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 1993;331:281-284.
5. Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med. 1993;14:303-311.
6. Farrera JA, Jauma A, Ribo JM, Peire MA, Parellada PP, Roques-Choua S, Bienvenue E, Seta P. The antioxidant role of bile pigments evaluated by chemical tests. Bioorg Med Chem. 1994;2:181-185.
7. Wu TW. Bilirubin analysis - the state of the art and future prospects. Clin Biochem. 1984;17:221-229.
8. Wu TW, Carey D, Wu J, Sugiyama H. The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Biochem Cell Biol. 1991;69:828-834.
9. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol. 1991;69:683-688.
10. Wu TW, Fung KP, Yang CC. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. Life Sci. 1994;54:P477-P481.
11. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994;269:16712-16719.
12. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
13. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
14. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet. 1993;341:1103-1104. Letter.
15. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454-457.
16. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011.
17. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease: The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA. 1994;272:1439-1441.
18. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40:18-23.
19. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, Ash KO. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 1988;62:703-707.
20. Cambien F, Richard J-L, Ducimetiere P. Family history is an independent risk factor. J Epidemiol. 1980;28:21-37.
21. Conroy RM, Mulcahy R, Hickey N, Daly L. Is a family history of coronary heart disease an independent coronary risk factor? Br Heart J. 1985;53:378-381.
22. Friedlander Y, Kark JD, Stein Y. Family history of myocardial infarction as an independent risk factor for coronary heart disease. Br Heart J. 1985;53:382-387.
23. Khaw K-T, Barrett-Connor E. Family history of stroke as an independent predictor of ischemic heart disease in men and stroke in women. Am J Epidemiol. 1986;123:59-66.
24. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol. 1984;4:793-801.
25. Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR, Hopkins PN. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clin Chem. 1994;40:552-561.
26. Jorde LB. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, insonymy, and migration matrices. Ann Hum Genet. 1989;53:339-355.
27. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet. 1984;36:836-857.
28. Lipid Research Clinics Program. Manual of Laboratory Operations. Washington, DC: Government Printing Office; 1974. US Dept of Health, Education, and Welfare publication NIH 75-628.
29. Wu LL, Warnick GR, Wu JT, Williams RR, Lalouel JM. A rapid micro-scale procedure for determination of the total lipid profile. Clin Chem. 1989;35:1486-1491.
30. Novros JS, Koch TR, Knoblock EC. Improved method for accurate quantitation of total and conjugated bilirubin in serum. Clin Chem. 1979;25:1891-1899.
31. Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown & Co; 1986.
32. Hopkins PN, Wu LL, Wu J, Hunt SC, James BC, Vincent GM, Williams RR. Higher plasma homocyst(e)ine and increased susceptibility to adverse effects of low folate in early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:1314-1329.
33. Ewen LM, Griffiths J. Patterns of enzyme activity following myocardial infarction and ischemia. Am J Clin Pathol. 1971;56:614-622.
34. Sharma SC. Serum unconjugated bilirubin and free fatty acids in acute myocardial infarction and angina. J Assoc Physicians India. 1985;33:473-475.
35. Benaron DA, Bowen FW. Variation of initial serum bilirubin rise in newborn infants with type of illness. Lancet. 1991;338:78-81.
36. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. N Engl J Med. 1995;332:1198-1203.
37. Yokode M, Kita T, Arai H, Kawai C, Narumiya S, Fujiwara M. Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci U S A. 1988;85:2344-2348.
38. Harats D, Ben-Naim M, Dabach Y, Hollander G, Stein O, Stein Y. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis. 1989;79:245-252.
39. Chan-Yeung M, Ferreira P, Frohlich J, Schulzer M, Tan F. The effects of age, smoking, and alcohol on routine laboratory tests. Am J Clin Pathol. 1981;75:320-326.
40. Gofin J, Kark JD, Halfon ST, Friedlander Y, Stein Y. Cigarette smoking and its relation to anthropometric characteristics and biochemical variables in Jerusalem 17-year-olds and adults. Isr J Med Sci. 1982;18:1233-1241.
41. Mercke C, Cavallin-Stahl E, Lundh B. Carbon monoxide production and reticulocyte count in normal women: effect of contraceptive drugs and smoking. Acta Med Scand. 1975;198:155-160.
42. Ellis FR, Montegriffo VM. Veganism, clinical findings and investigations. Am J Clin Nutr. 1970;23:249-255.
43. White GL, Nelson JA, Pedersen DM, Ash KO. Fasting and gender (and altitude?) influence reference intervals for serum bilirubin in healthy adults. Clin Chem. 1981;27:1140-1142. Letter.
44. Leibson C, Brown M, Thibodeau S, Stevenson D, Vreman H, Cohen R, Clemons G, Callen W, Moore LG. Neonatal hyperbilirubinemia at high altitude. Am J Dis Child. 1989;143:983-987.